in combination with a steroid taper regimen in adults with giant cell arteritis (GCA). The multicentre, randomised, double-blind, placebo-controlled trial enrolled 428 patients. Divided into two ...
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...
double-blind placebo-controlled study designed to evaluate the safety and efficacy of upadacitinib in 428 patients with GCA. The study consists of two periods. The first period, which is reported ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果